US biotech AeroRx Therapeutics has secured $21 million in Series A financing to advance its lead program, AERO-007, into ...

Sales of bioAffinity's CyPath® Lung test for lung cancer reached a new high in Q3 2025, representing a 95% increase over the ...

The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...

A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD). The blood test ...

Please provide your email address to receive an email when new articles are posted on . Risk for COPD, respiratory-related mortality and a respiratory exacerbation could be found via blood test. More ...

Select your location to view local American Lung Association events and news near you.

We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be early signs of chronic obstructive pulmonary disease (COPD). If you have ...

为探索慢性阻塞性肺疾病（COPD）早期风险因素，研究人员开展了一项针对895名青年人的纵向研究，发现除吸烟（导致FEV1下降1.95%）外，体重指数（BMI）每增加1 kg/m2和C反应蛋白（CRP）每升高1 mg/dL分别导致FEV1额外下降0.28%和0.76%，提示代谢性炎症可能参与COPD发展进程。